Arrowhead Research Corporation
$65.79
-$4.88 (-6.91%)
$64.50Day Range$71.93
Key Statistics
Market Cap
$9.98B
Shares Outstanding
141.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 1, 1995
Round Lot
100
Locale
US
Trading Data
Day Open
$70.41
Day High
$71.93
Day Low
$64.50
Volume
5.11M
VWAP
$66.98
Prev Close
$70.67
Transactions
--
Acc. Volume
--
About Arrowhead Research Corporation
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
PHARMACEUTICAL PREPARATIONSSIC 2834711 employees177 E COLORADO BLVD, PASADENA, CA, 91105626-696-4702IPO Feb 1, 1995US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000879407
- Composite FIGI
- BBG000BRVKH0
- Share Class FIGI
- BBG001SGT8G5
- Ticker Root
- ARWR
- SIC Code
- 2834
About Arrowhead Research Corporation (ARWR) Stock
Arrowhead Research Corporation (ARWR) closed the 2026-09-16 session at $65.79, down 6.91% versus the previous close (-4.88). The stock opened at $70.41 and traded between $64.50 and $71.93 during that session. Session trading volume was 5.1M shares. The volume-weighted average price (VWAP) is $66.98.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Arrowhead Research Corporation has a market capitalization of $9.98 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ARWR is listed on the XNAS exchange. The company employs approximately 711 people. Arrowhead Research Corporation is headquartered in PASADENA, CA. The recorded listing date is 1995-02-01.
On this page you can find market ARWR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.